-
Launch of GLYPRESSIN
TIMELINES oninFirst registration and launch of GLYPRESSIN® (terlipressin), an analogue of vasopressin, which is used for the treatment of bleeding oesophageal…
0 -
New production site
TIMELINES oninFerring established its first production site outside Scandinavia in Kiel, Germany.
-
Launch of MINIRIN
TIMELINES oninFerring launched MINIRIN®, an anti-diuretic hormone used initially to treat diabetes insipidus and later primary nocturnal enuresis, or bedwetting. MINIRIN…
-
Expansion
TIMELINES oninAn important breakthrough for Ferring came when Dr. Paulsen and his staff succeeded in producing synthetic peptide hormones (vasopressin and…
-
Expansion
TIMELINES oninFerring moved from its rented location to its first self-owned factory in Malmö. As Ferring grew, companies opened in Germany…
-
Strong roots decide name
TIMELINES oninFrederik Paulsen changed the company name to Ferring. He had practical and rational reasons for renaming the company; he wanted…
-
Laying the foundation for Ferring
TIMELINES oninIn the spring Nordiske Hormonlaboratorie started the production of adrenocorticotrophic hormone (ACTH) on rented 60 square metres in an old…
-
Laying the foundation for Ferring
TIMELINES oninDr. Frederik Paulsen and Eva Frandsen incorporated ‘Nordiske Hormonlaboratorie’, later to be named Ferring. The company wanted to be a…
Author archive for pulse
Articles by: pulse